Olmesartan in Essential Hypertension

Clinical trial NCT00185172 · COMPLETED

Trial details

NCT number: NCT00185172
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2002-01-01
Primary completion: 2005-06-01
Enrollment: 2333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.